Zepbound linked to lower healthcare costs in adults over age 55 with obesity according to a real-world study

Wait 5 sec.

First-of-its-kind study shows sustained Zepbound use in older adults with obesity lowers costs, reinforcing the potential value of the Medicare GLP-1 Bridge program Individuals treated with Zepbound had lower rates of hospital admissions and emergency department visits INDIANAPOLIS, Aug....